Ra Medical Systems received notification of allowance of the first patent to be issued for the company’s LockeT product. Entitled “Vessel Closing Device”, the patent to be granted is one in a family of six patent applications on file in the US, and in a number of foreign countries, including the European Community, Japan, and China. This new patent will join the company’s library of over fifty patents and patent applications on the company’s three cardiology technologies.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RMED:
- Is RMED a Buy, Before Earnings?
- Ra Medical Systems reports VIVO used in over 1000 procedures
- Ra Medical Systems announces proposed name, ticker symbol change
- Ra Medical Systems sees increase in clinical adoption of VIVO System
- Ra Medical Systems says LockeT device utilized in structural heart procedures
